Related by context. All words. (Click for frequent words.) 64 purified recombinant 63 isoform selective 63 Novosom 63 recombinant plasma 63 rxRNA 62 selective kinase inhibitors 62 siRNA therapeutics 62 Anticalins R 62 peptidomimetic 62 novel peptide 61 biologic therapeutics 61 Onconase 61 ghrelin antagonist 61 immune modulating 61 AMPK activators 61 miRagen 61 combinatorial libraries 61 targeted radiotherapeutic 61 XmAb 61 therapeutic monoclonal antibody 61 Fc fusion protein 61 Receptos 61 HSP# inhibitor 61 protein biosynthesis 61 immatics 60 siRNA therapeutic 60 AAG geldanamycin analog 60 Capsulution 60 Locus Pharmaceuticals 60 therapeutic monoclonal antibodies 60 MediVas 60 Squalamine 60 HER1 60 antiproliferative activity 60 Factor VIIa 60 Anticalin 60 GMX# 60 Antisense 60 Phage Pharmaceuticals 60 Fleximer 60 metabolite profiling 60 anti CD3 60 PDE4 inhibitor 60 peptide therapeutics 60 protein homeostasis 60 Syntonix 60 potent cytotoxic 59 Anavex #-# 59 systemic RNAi 59 clinically differentiated 59 A3 adenosine receptor 59 novel therapeutic antibodies 59 potently inhibit 59 Enkephalin 59 TLR agonists 59 DNA methyltransferases 59 OvaRex R 59 humanized monoclonal 59 intracellular uptake 59 polyketides 59 enGene 59 RNA antagonist 59 anticoagulant reversing agent 59 targeted antifolate 59 γ secretase 59 Metallophile ™ Technology 59 immunotoxin 59 recombinant antibodies 59 shRNA libraries 59 PROfusion 59 galectin 59 vascular disrupting agents 59 Fleximer R 59 proprietary PEGylation 59 metalloenzymes 59 BioLeap 58 DepoVax TM 58 Ambrx 58 small molecule tyrosine 58 beta secretase inhibitors 58 Fibroblast Growth Factor Receptor 58 Saegis 58 Celator 58 THR beta agonist 58 acetylcholinesterase AChE 58 selective inhibition 58 A2A receptor 58 aTyr Pharma 58 Anticalins ® 58 biotherapeutics 58 MorphoSys proprietary 58 Adenosine Therapeutics 58 Panzem 58 Vysis 58 pan HDAC inhibitor 58 antiapoptotic 58 druggable target 58 GIPET 58 liposomal delivery 58 Pepducin 58 ProMIS TM 58 potency selectivity 58 Ostabolin C TM 58 ADME properties 58 PEGylated 58 ArQule Kinase Inhibitor Platform 58 lipid nanoparticle 58 Micromet BiTE 58 bioconjugation 58 aTyr 58 micellar 58 anticancer therapeutics 58 synthetic peptides 58 PORxin TM 58 Spiegelmer 58 ProNAi 58 Anticalins 58 Catalyst Biosciences 58 orally bioavailable 58 SMIP 58 oral taxane 58 Panzem R 58 novel peptides 58 HCV protease inhibitors 58 TLR9 agonist 58 polyketide 58 PF # [002] 58 JAK1 58 Gamma secretase 58 humanized antibody 58 Vaccinex 58 ENMD # 58 Vegenics 58 RNA antagonists 58 immune stimulatory 58 ADME Tox 58 stapled peptides 58 HSP# inhibitors 58 Adnectin 58 tiapamil 58 detection reagents 58 predictive biomarkers 58 JAK3 57 Epitome Biosystems 57 superior biotherapeutics 57 Intarcia 57 GelSite R polymer 57 enzyme inhibitor 57 Protein Kinase C 57 immunotoxins 57 NS4B 57 epothilone 57 epothilones 57 PhaseBio 57 Receptors GPCRs 57 PDE# inhibitors 57 HyACT 57 Intellikine 57 Lycera 57 Isis antisense 57 biosynthetic 57 pharmacological chaperone 57 Nautilus Biotech 57 defensin mimetic antibiotic 57 Trophos 57 sirtuin therapeutics 57 Charlesson 57 Senexis 57 targeting CD# 57 Novavax VLP vaccine 57 pegylation 57 Symadex 57 medicinal chemists 57 Supernus Pharmaceuticals 57 NEUGENE R 57 molecular biomarkers 57 targeting PCSK9 57 ActivX 57 Janus Kinase 57 small molecule activators 57 tkRNAi 57 Cellerant 57 ZFP technology 57 Monoclonal antibody 57 biotherapeutic 57 Alfacell proprietary ribonuclease 57 OTCBB PWRM.OB 57 Curaxin 57 selective immunoproteasome inhibitor 57 dasatinib Sprycel 57 mda 7 57 metabolite identification 57 RayBiotech 57 PRLX # 57 therapeutics diagnostics 57 oxazolidinone 57 Aganocide TM 57 MEK inhibitors 57 GlycosBio 57 Phylomer 57 nutlin 57 Litx 57 proprietary LNA 57 Immunotherapeutic 57 humanized monoclonal antibodies 57 prostone 57 bioseparation 57 histone acetyltransferase 57 Relypsa 57 Nanobody ® 57 Bassil Dahiyat Ph.D. 57 potent inhibitors 57 radioprotective 57 Spiegelmers 57 Aurora kinase 57 TGR5 56 ligand binding 56 Odyssey Thera 56 ARRY # 56 promising anticancer 56 Velcura 56 intranasal delivery 56 Preclinical studies suggest 56 vinca alkaloid 56 apoptosis inducing 56 Activity Assay 56 combinatorial chemistry 56 KineMed 56 Xencor 56 biased ligand 56 HepDirect 56 G Protein Coupled 56 histone deacetylase inhibitor 56 nicotinic alpha 7 56 antisense inhibitor 56 poly ADP ribose polymerase 56 DNAi 56 JAK2 inhibitor 56 geldanamycin 56 druggable 56 pharmacophore 56 MTP inhibitor 56 Virdante 56 Anticalin ® 56 antisense oligonucleotide 56 DiLA2 56 oligonucleotide therapeutics 56 CB2 selective 56 FGFR 56 Taligen 56 Cylene 56 predictive toxicology 56 MDRNA proprietary 56 p# inhibitor 56 vivo RNAi 56 anticancer compounds 56 VaxImmune 56 investigational HCV polymerase 56 AC Immune 56 Archexin 56 Vivecon 56 Viamet 56 AtuRNAi 56 PI3K/mTOR 56 adenoviral 56 Oligonucleotide 56 ProLindac TM 56 outlicensing 56 Nanotope 56 vitro ADME 56 Zacharon 56 DXL# 56 SoluBest 56 CureDM 56 Theranostics 56 novel immunotherapeutic 56 inhibiting tumor 56 selective adenosine 56 Galenea 56 Chemokine 56 antiangiogenic 56 bicyclic 56 Panzem NCD 56 molecular imaging radiopharmaceutical 56 gamete formation 56 glycomics 56 BIOCIUS Life Sciences 56 histone deacetylase 56 metabonomics 56 MAXY VII 56 intercellular signaling 56 Santaris 56 asymmetric catalysis 56 selective orally bioavailable 56 EndoTAG TM 56 molecule therapeutics 56 ZFP Therapeutics 56 miRNA therapeutics 56 Systemic Delivery 56 thermostable 56 tubulin inhibitor 56 FGFR3 56 HTS assay 56 UCOE 56 Genedata Expressionist ® 56 Epizyme 56 Semafore 56 engineered proteases 56 Evolva 56 ANAVEX 56 AMPAKINE 56 ribonuclease 56 Acetylon 56 Locked Nucleic Acid LNA 56 therapeutic mAbs 56 ERYtech 56 metaglidasen 55 Stapled Peptide 55 UltiMAb 55 adrenergic regulation 55 ADME 55 peptide conjugated 55 Pentad TM 55 Captisol ® 55 LentiVector 55 Peptimmune 55 therapeutic peptides 55 ALK inhibitors 55 Personalized Immunotherapy 55 chemically modify 55 prostanoid 55 Panzem R NCD 55 ligand induced 55 Nanobody 55 Marqibo TM 55 IIB ActRIIB 55 Zysolin TM 55 IAP inhibitors 55 DNA gyrase 55 Alantos 55 CCR9 antagonist 55 optical biosensors 55 siRNA sequences 55 CRAC channel 55 Lixivaptan 55 intracellular protein 55 PEGylation 55 IMiDs ® 55 Kiadis 55 bioactive compound 55 oral prodrug 55 novel immunomodulatory 55 glycogen synthase 55 RapMAT 55 EGIR 55 therapeutics 55 siRNAs targeting 55 PathHunter 55 Chemokine Therapeutics 55 LEX System 55 epigenetic therapies 55 PLx 55 TargeGen 55 RNA Interference 55 maturation inhibitors 55 Synageva 55 molecular chaperone regulation 55 Chiral Quest 55 novel anti infective 55 Astex 55 Phylogica 55 Sphingomab TM 55 novel anticancer 55 Atugen 55 DCCR 55 neuro protective 55 including eniluracil ADH 55 bluebird bio 55 OXIGON TM 55 ELND-#/AZD-# 55 GeneICE 55 Pervasis 55 bifunctional 55 PEGylated interferon 55 RNAi therapeutic targeting 55 stem cell pluripotency 55 IAP inhibitor 55 allosteric modulation 55 fermentative 55 polymerase inhibitors 55 Amarantus 55 Anaphore 55 antisense oligonucleotides 55 P#X# 55 motexafin gadolinium 55 multitargeted 55 Myocet 55 VentiRx 55 SERMs 55 Creabilis Therapeutics 55 engineered RAP peptides 55 Chronogen 55 EndoTAG 55 DOS# 55 protein biochip 55 molecularly targeted 55 Zyngenia 55 oral PTH 55 trastuzumab DM1 T DM1 55 nanopharmaceuticals 55 Agios Pharmaceuticals 55 antitumoral 55 Genstruct 55 Amunix 55 KeyGene 55 Delenex 55 PDGF receptor 55 Maxy G# 55 pathophysiological effects 55 HuCAL antibodies 55 cytotoxics 55 bioimaging 55 potent antiproliferative 55 RECOTHROM R 55 GPR# agonists 55 MEK inhibitor 55 vivo potency 55 methyltransferase 55 osteoconductive 55 trans splicing 55 Histone deacetylase 55 tissue fibrosis 55 FORMA 55 Cyclosert 55 HepDirect R 55 HuCAL R 55 NormOxys 55 biomarker assays 55 OHR/AVR# 55 romazarit 55 Mimotopes 55 ddRNAi 55 PSN# [001] 55 MAb 54 biotherapies 54 Cenomed 54 VisEn Medical 54 CardioVascular BioTherapeutics 54 Potelligent Technology 54 Cellzome 54 CXCR4 receptor 54 keratinocyte 54 recombinant fusion 54 LNP formulations 54 OMP #M# 54 cartilage regeneration 54 XmAb ™ 54 HCV polymerase 54 oncolytic 54 immunoregulatory 54 ZEVALIN ® 54 Phylomer ® 54 mGluR2 NAM 54 S#P# 54 Endotis 54 immunotherapeutic vaccine 54 ligases 54 antimitotic 54 DP VPA 54 VeraTag 54 personalized immunotherapy 54 EGEN 54 XmAb ® 54 immunomodulation 54 elbion 54 iCeutica 54 cyclic adenosine monophosphate cAMP 54 RNA therapeutics 54 theranostic 54 Proteros 54 JAK inhibitors 54 Syndax 54 biomarker identification 54 antisense inhibitors 54 Mersana 54 Dimerix 54 therapeutically useful 54 CrystalGenomics 54 monoclonal antibody mAb 54 Nereus Pharmaceuticals 54 Regulus Therapeutics 54 Alligator Bioscience 54 Plasticell 54 neurology immunology 54 p# activation 54 Aquinox 54 RNA silencing 54 kidney urologic 54 ActA 54 small molecule agonists 54 Tacere 54 Cyclin E 54 Technology LVT 54 Novasome R 54 protein misfolding diseases 54 Zelos Therapeutics 54 AKT inhibitor 54 IL-#/# 54 Locked Nucleic Acid 54 proteasome inhibitor 54 immuno modulatory 54 Pancreate 54 biocompatible coatings 54 diagnostic biomarker 54 VDAs 54 PET molecular imaging 54 Raven Biotechnologies 54 Ilypsa 54 gamma secretase inhibitors 54 Sphingomab 54 arGentis 54 AEG# 54 enhance ApoA 54 inosine 54 tranilast 54 UsiRNAs 54 anti CD# antibodies 54 eukaryotic translation 54 DPX Survivac 54 MAbs 54 sd rxRNA 54 mechanistic insights 54 xenograft models 54 metabolomic profiles 54 CRACM 54 receptor antagonism 54 Bioral 54 Aptamer 54 chimeric monoclonal antibody 54 sphingolipid 54 BioFocus DPI Galapagos 54 monoclonal antibody therapeutics 54 transfection reagents 54 Psynova 54 lipid nanoparticles 54 biocatalysis 54 DiaKine 54 inhibits VEGF 54 inhibit viral replication 54 muscarinic antagonist 54 Hsp# inhibition 54 Metaphore 54 DXL TM 54 hematological tumors 54 anti CD3 monoclonal 54 cationic lipid 54 outlicensed 54 IDO inhibitor 54 neurotrophic 54 Phase IIb clinical trials 54 commercialize microRNA 54 Cancer Vaccines 54 Nanobodies 54 ImmuneY2 54 theranostics 54 anti infective treatments 54 Affimed 54 therapeutic antibody 54 binds selectively 54 ImmunoCellular Therapeutics 54 telomerase inhibitor 54 protein tyrosine kinase 54 therapeutic peptide 54 adult mesenchymal stem 54 Interferon beta 54 dAbs 54 enzyme inhibitors 54 Ramoplanin 54 dimensional nanostructures 54 exon skipping 54 nucleosides 54 GPCRs 54 Scancell 54 investigational humanized monoclonal antibody 54 novel immunotherapies 54 NanoCrystal technology 54 Biomerk Tumorgrafts 54 siRNA delivery 54 Avila Therapeutics 54 rxRNA compounds 54 DermTech 54 recombinant protein 54 synthases 54 hydrolytic 54 synthetic peptide containing 54 potent anticancer 54 Harry Palmin President 54 mimetic compounds 54 Small Molecule 54 Guanilib 54 MacuSight 54 translational genomics 54 peptidic 54 SGLT inhibitors 54 Fibrocell Science 54 clinically validated targets 54 calcitonin gene related 54 buccal delivery 54 NNRs 53 potent antibacterial 53 Pertuzumab 53 Regado 53 molecularly targeted therapy 53 TapImmune 53 Aegis Therapeutics 53 Smac mimetics 53 siRNA Delivery 53 Vincent Mutel CEO 53 InteKrin 53 biocatalysts 53 nanoparticulate 53 DermTech International 53 Prolexys 53 ESBA# 53 NewLink 53 Enanta Pharmaceuticals 53 Mpex 53 AKT1 53 Affibody 53 Hybridon 53 protein kinase inhibitors 53 mTOR mammalian target 53 TLR Therapeutics 53 CYT# potent vascular disrupting 53 glucokinase activator 53 ATL# [001] 53 Factor Receptor 53 PI3K inhibitor 53 Crop BioScience 53 SNALP technology 53 renin inhibitor 53 adenosine A2A 53 chemoinformatics 53 Galectins 53 Piramed 53 Corgentin 53 ATD gel 53 triphendiol 53 Therapeutic Antibody 53 Eg5 53 neuroprotective properties 53 Ensysce 53 Wnt signaling pathway 53 aptamer therapeutics 53 Octreotide 53 lentiviral vectors 53 drug conjugate 53 NEUGENE 53 topical dermatology 53 oncolytic virus 53 Dyax phage display 53 Trellis Bioscience 53 Assay Designs 53 regenerative therapeutics 53 c MET 53 Nektar pulmonary 53 TMEM#B 53 nucleoside 53 Interferon alpha 53 vidofludimus 53 Promedior 53 enzymology 53 sGC 53 therapeutic modality 53 NMDA antagonist 53 molecularly targeted therapies 53 CCR2 53 prodrugs 53 preclinically 53 RONDEL ™ 53 histone deacetylase HDAC 53 potentiator 53 adipogenesis 53 IMiDs R 53 CD# antibody [001] 53 VEGF receptor 53 Akebia Therapeutics 53 Transfection Reagent 53 Calibrant 53 inhibit metastasis 53 Kalypsys 53 PML RARA 53 Tyrima 53 Zybrestat 53 medicinal chemistry 53 Alnylam RNAi 53 Phytomedics 53 c MYC 53 mAbs 53 mTOR inhibition 53 ALN PCS 53 immunostimulatory effects 53 nanomedicines 53 anti amnesic 53 RhuDex ® 53 mAb 53 Prodarsan R 53 Stapled Peptides 53 cytostatic 53 VistaGen 53 Nanobodies ® 53 Prima BioMed 53 SuperAntibody 53 Argolyn 53 fusion enhancers 53 vivo validation 53 Anticalin R 53 Spherics 53 peptide synthesis 53 Numoda 53 cytoprotective 53 Enzo Therapeutics 53 p#/CBP 53 demethylase 53 biodegradable nanoparticles 53 oral antiviral 53 gefitinib Iressa 53 VR1 53 CGRP calcitonin gene 53 pharmaceuticals biopharmaceuticals 53 Profectus BioSciences 53 BioSilicon 53 KaloBios 53 melanocortin receptor agonists 53 hereditary emphysema 53 Myolimus 53 antisense drug 53 SomaLogic 53 antagomirs 53 mGluR5 antagonist 53 Ridaforolimus 53 P#X# antagonist 53 anti neoplastic 53 NovaCal 53 orally bioavailable mimics 53 ADME PK 53 redox active 53 TLR9 agonists 53 immunotherapeutics 53 SCIB1 53 biologic therapies 53 isoprenoid 53 treats acute lymphoblastic 53 novel antiviral therapeutics 53 act synergistically 53 antiproliferative effects 53 therapeutically relevant 53 cancer immunotherapies 53 histone deacetylase HDAC inhibitors 53 Affymetrix microarray technology 53 BAL# [002] 53 telomerase therapeutic 53 Hyaluronan 53 OncoVEX 53 OGeS 53 Cellgate 53 recombinant factor VIIa 53 transfection reagent 53 Mipomersen 53 GGF2 53 antiangiogenesis 53 therapeutic radiopharmaceuticals 53 CB2 receptor 53 recombinant protein therapeutics 53 PharmaDirections 53 small molecule inhibitors 53 EHT AGN 53 norepinephrine reuptake inhibition 53 vitamin D analogs 53 splice variants 53 Hyaluron 53 dAb 53 specialty biotherapeutics 53 immunomodulating 53 chimeric protein 53 Caris MPI 53 New Chemical Entities 53 MP4 molecule 53 enzymatically active 53 morpholino 53 PI3K inhibitors 53 SGLT Inhibitors 53 SR Pharma 53 anti tumoral 53 ORTHOCON 53 NuMimetic TM 53 antiangiogenic agents 53 kinase pathway 53 GRNVAC1 53 SIRT1 activators 53 Ascentage 53 Dr. Aiping Young 53 cytotoxic T lymphocyte 53 anticancer therapies 52 iRGD 52 Smac mimetic 52 tumor vascular disrupting 52 TG# [003] 52 miRagen Therapeutics 52 NNR Therapeutics 52 nonviral 52 chemokine receptor 52 Abnova 52 Abiraterone 52 lysophosphatidic acid LPA 52 NTDDS 52 developing TB4 52 MolecularBreeding 52 Protein Interactions 52 diagnostic biomarkers 52 Apo2L 52 deforolimus 52 small molecule 52 BiolineRX 52 druggable targets 52 osteoblastic 52 NS4A 52 KuDOS 52 anti CD# monoclonal 52 receptor ligand 52 CRTH2 52 biased ligands 52 extracellular proteins 52 subtype selective 52 vivo molecular imaging 52 Zemiva TM 52 PARP inhibitor 52 Wellstat 52 protein tyrosine phosphatase 1B 52 hypoxia activated prodrug 52 Etubics 52 Cyclosert TM 52 plasma proteome 52 HDAC6 52 liposome encapsulated 52 Pfenex Expression Technology 52 PARP Inhibitor 52 preclinical 52 HIV integrase inhibitors 52 microtubule inhibitor 52 Thiovir 52 mGlu2 3 52 volociximab 52 antiviral therapeutics 52 Enhanze 52 SGLT2 inhibitors 52 novel RNAi therapeutics 52 TLR8 52 iPSC 52 delta isoform 52 DsiRNA 52 Civacir 52 ZFP TF 52 FivePrime 52 SCD1 52 patented Bioral 52 inhibit angiogenesis 52 Cytomyx 52 Histogen 52 PathFinderTG 52 small molecule modulators 52 biosurgical 52 Aegerion Pharmaceuticals 52 XmAb# 52 genomic proteomic 52 oral immunomodulatory 52 enzymatic pathways 52 Vaxart 52 antihormonal 52 BrachySil TM 52 GAP #B# 52 oral ghrelin agonist 52 TransVax tm 52 Spiegelmers ® 52 M1 muscarinic 52 Sangamo ZFP technology 52 GPx 52 monoclonal 52 eBioscience 52 Oasmia 52 preclinical efficacy 52 Aegera 52 IGF 1R inhibitor 52 biocatalytic 52 LSD1 52 FluoroPharma 52 Corixa Corporation 52 DNA adducts 52 deacetylase inhibitors 52 glycolytic 52 nitric oxide donating 52 immunodiagnostics 52 Ception Therapeutics 52 ACTCellerate 52 miR #a [002] 52 suppresses tumor 52 Captisol 52 hypoxia inducible factor 52 prophylactic vaccines 52 galectins 52 thymidylate synthase TS 52 protein ligand interactions 52 BioSurgery 52 immuno therapeutic 52 HIV protease 52 HuLuc# 52 eTag assays 52 biomarker validation 52 Urokinase 52 biosynthetic pathway 52 Aviptadil 52 oncology therapeutics 52 drug GAP #B# 52 Affinitak 52 receptor partial agonist 52 matrix metalloproteinases 52 stent coating 52 Therapeutic antibodies 52 DMPK 52 CellMed 52 auristatin 52 PolyTherics 52 Gemzar gemcitabine 52 vitro pharmacology 52 immuno oncology 52 SCYNEXIS 52 MRC LMB 52 ibritumomab tiuxetan 52 molecular chaperone amplification 52 Innate Pharma 52 humanised monoclonal antibody 52 Selective Electrochemical Tumor Ablation 52 Factor NGF 52 Molecular Profiling 52 toxicogenomics 52 HTRF 52 Surface Logix 52 Intrinsic Bioprobes 52 targeted radiotherapeutics 52 SNALP 52 inhibits tumor 52 antiviral therapies 52 OnDose 52 excision repair 52 mitotic kinesin 52 antigen sparing 52 cGMP manufacture 52 Anidulafungin 52 Diabetica 52 Quark Pharmaceuticals 52 vaccine GRNVAC1 52 KL4 surfactant 52 erlotinib Tarceva 52 oral dnaJP1 52 KinomeScan 52 TÎ ² 4 52 radiation sensitizer 52 Captisol enabled 52 kinase inhibition 52 delipidation 52 ParAllele 52 ibudilast 52 vitro assay 52 Prism Pharmaceuticals 52 gallium containing 52 catalytic antibodies 52 nicotinic 52 OxBC 52 binding affinities 52 proteasome inhibitors 52 proteomics bioinformatics 52 diagnostic prognostic 52 Tranzyme 52 ProFibrix 52 RenaMed 52 Tekmira lipid nanoparticle 52 ZFN technology 52 vaccines oncolytic virus 52 oral salmon calcitonin 52 nanoparticle formulation 52 oncology immunology 52 FoldRx 52 peptides proteins 52 Dr. Bert Vogelstein 52 bioinnovation 52 Ibis Biosciences 52 hyperphosphorylation 52 Fc receptor 52 INT# [002]